GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] Poland — has anyone got a straight answer on special authorization — 14 comments in the full submission. View in context.
101
c/glp1canada·submitted 24 days ago by u/dario_vermeulen

[Question] Poland — has anyone got a straight answer on special authorization

Questionbranch of 8 comments

Poland — has anyone got a straight answer on special authorization. I am not trying to be the "source?" guy. I would just like a source. Spent three weeks on what turned out to be a quantity limit rather than a coverage question. The pharmacist sorted in five minutes what the phone line had not managed in a…

Read the full submission and all 14 comments →

This branch

8 comments, started 24 days ago
u/emil_barros11 points·24 days ago

Criteria changed at plan renewal and the denial that had been immovable simply did not apply any more.

replysharereportpermalink
u/lane_watchermod · logistics3 points·23 days ago

Has your plan renewed since the last time you applied?

replysharereportpermalink
u/paper_trail_paulavetting4 points·23 days ago

special authorization forms are published, read them before applying

replysharereportpermalink
u/liv_dumitru3 points·23 days ago

Kept every form and reference number. When they had no record of a submission, I did.

replysharereportpermalink
u/dario_vermeulenOP2 points·23 days ago

Those criteria were revised at renewal, so the version quoted upthread is out of date.

replysharereportpermalink
u/kian_ekstrom5 points·23 days ago

quantity limits are as common a barrier as coverage itself

replysharereportpermalink
[deleted]4 points·23 days ago

[deleted]

replysharereportpermalink
u/aurel_lindqvist6 points·23 days ago·edited

Have you seen the special authorization criteria for your province?

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.